Emergent BioSolutions Inc

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 20, 2021 at 9:00am EDT

06 May 2021 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions to Participate in Investor Conferences

05 May 2021 16:05:02 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: Emergent BioSolutions Inc

05 May 2021 09:45:03 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

04 May 2021 09:45:15 By NetDania Notify

Emergent BioSolutions Reports Financial Results for First Quarter 2021

29 Apr 2021 16:05:02 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: Emergent BioSolutions Inc

23 Apr 2021 11:23:28 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

22 Apr 2021 09:45:05 By NetDania Notify

Statement on Issuance of Form FDA 483 at Emergent Bayview Facility

21 Apr 2021 12:46:42 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: Emergent BioSolutions Inc

20 Apr 2021 09:47:04 By NetDania Notify

Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021

15 Apr 2021 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments; Receives Modified Task Order from the U.S. Department of Health & Human Services to Support the Opportunity for Further Expansion of Manufacturing Capacity for Johnson & Johnson’s COVID-19 Vaccine

04 Apr 2021 22:09:06 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Immunoglobulins as a Treatment for Hospitalized Patients with COVID-19

02 Apr 2021 08:00:00 By Nasdaq GlobeNewswire

Emergent BioSolutions to Participate in Investor Conferences

01 Mar 2021 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020

18 Feb 2021 16:05:01 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release Fourth Quarter and Full Year 2020 Financial Results and Conduct a Conference Call on February 18, 2021

04 Feb 2021 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results

10 Jan 2021 14:00:00 By Nasdaq GlobeNewswire

Emergent BioSolutions to Participate in Investor Conferences

04 Jan 2021 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for Prophylaxis

29 Dec 2020 16:05:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 and Updates Full Year 2020 Guidance

05 Nov 2020 16:05:03 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release Third Quarter 2020 Financial Results and Conduct Conference Call on November 5, 2020

15 Oct 2020 06:30:10 By Nasdaq GlobeNewswire